BONE BIOLOGICS CORP (BBLG)

These stocks are moving in today's after hours session

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning!

Bone Biologics CEO Issues Letter to Stockholders

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that Bone Biologics...